Gary Taylor

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

F. Markowetz, T. Bray, Shruti Singh, 2020, The Lancet.

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Roger A. Nadeau, Jonathan B Sumner, T. Furukawa, 2022, Clinical Research in Cardiology.